1. Introduction: The “Edge Effect” in Wound Bed Preparation
In our roles as clinical specialists, we recognize that a wound’s margin is more than a boundary; it is a clinical alarm bell. According to the 2021 Wound Bed Preparation (WBP) paradigm (Statement 9), the “Edge Effect” is a critical indicator of whether our management strategy is succeeding or failing. We must be rigorous in our assessment: a healable wound on a positive trajectory should demonstrate a 20% to 40% reduction in surface area by week 4. This metric is our most reliable predictor of 12-week healing success.
When the wound edge fails to migrate—remaining stationary despite standard interventions—it signifies a failure in the underlying molecular and cellular environment. As specialists, we cannot afford a “wait and see” approach. A stalled edge is a definitive signal to re-evaluate the diagnosis, treat the underlying cause, and escalate to active therapies to refresh the healing cycle.
2. The Pathology of Stalled Edges: Identifying the Barriers
To restart the stalled edge, we must first understand the physical and invisible obstacles preventing epithelial advancement.
Epibole and Hyperkeratosis
Physically, migration is often halted by epibole (rolled, thickened edges) and hyperkeratosis (callus formation). These conditions indicate that keratinocytes have ceased horizontal migration and have instead begun to proliferate downward or thicken at the margin. These non-viable tissues effectively “seal” the wound, creating a physical roadblock that necessitates mechanical or surgical removal.
The Invisible Barrier: Biofilm
Don’t be fooled by the lack of classic infection signs; biofilms are present in 60% to 90% of chronic wounds. These complex microbial communities are embedded in a protective EPS (extracellular polymeric substance) matrix that shields them from systemic antibiotics and host immune cells.
In clinical practice, we must suspect biofilm when we observe:
- Failure of appropriate systemic antibiotic treatment.
- Recalcitrance to standard topical antimicrobials.
- Low-level chronic inflammation or erythema.
- Poor granulation or the presence of friable, red hypergranulation.
- Failure of the wound to progress despite optimal moisture and pressure management.
The Sibbald Cube: Proteases and Compartments
The “Sibbald Cube” (2021) provides the necessary framework for understanding why these edges stall. It illustrates the interplay between the Superficial and Deep compartments across two primary barriers: Infection and Proteases. We must remember that a stalled edge is often the result of high protease levels (such as MMPs and elastase) acting in both compartments. These proteases degrade the extracellular matrix and essential growth factors, creating an indolent environment. Furthermore, the cells at the margin often enter senescence, a state where they remain metabolically active but are biologically “stalled,” no longer capable of the proliferation or migration required for closure.
3. Clinical Interventions: The Debridement Gold Standard
Debridement is our primary tool to “reset” the wound into an acute-like state. For healable wounds, Statement 5 of the WBP 2021 paradigm is clear: we must consider sharp surgical debridement to bleeding tissue. This aggressive approach is not merely about removing debris; it is a biological “reset.” By debriding to bleeding tissue, we physically remove senescent cells and refresh the wound margins, stimulating a new inflammatory response and “resetting” the biological clock for epithelial migration.
Selective vs. Non-Selective Methods
Choosing a modality requires balancing speed, selectivity, and patient comfort. Note that in the table below, a score of 5 represents the least desirable outcome (e.g., the highest pain level).
| Debridement Modality | Speed | Selectivity | Pain |
| Sharp Surgical | 1 (Fastest) | 3 | 5 (Highest Pain) |
| Conservative Sharp | 1 | 3 | 5 |
| Biologic (Maggot) | 2 | 2 | 3 |
| Enzymatic | 3 | 1 (Most Selective) | 2 |
| Mechanical | 4 | 5 (Least Selective) | 4 |
| Autolytic | 5 (Slowest) | 4 | 1 (Least Pain) |
4. Managing the Microenvironment: Antimicrobials and Moisture
Bacterial Balance: NERDS and STONEES
We must distinguish between superficial and deep involvement to guide treatment:
- Local Infection (NERDS): (Nonhealing, Exudate increase, Red friable granulation, Debris, Smell). Managed with topical agents.
- Deep/Spreading Infection (STONEES): (Size enlargement, Temperature increase of ≥3°F over mirror image, Os/probes to bone, New breakdown, Erythema/Edema, Exudate, Smell). This requires systemic intervention.
The Topical Toolkit: Release vs. Non-Release
Selection of antimicrobials must be precise. As specialists, we know that antiseptics in dressings are often preferable to irrigation because they provide longer contact time with less tissue toxicity.
- “Release” Technologies (Silver, Iodine/Cadexomer): These agents release antimicrobial ions into the wound, allowing them to penetrate the superficial compartment and treat local infection. Cadexomer iodine is particularly effective at disrupting mature biofilm.
- “Non-release” Technologies (PHMB Gauze): These work as a bacterial barrier above the wound surface. The antimicrobial stays in the gauze to prevent proliferation within the dressing but does not penetrate the wound surface compartment.
- Medical Grade Honey: Inhibits biofilm growth by disrupting quorum sensing and reducing colony formation.
Moisture Management
Statement 7 reminds us that moisture balance is the “tightrope” of wound care. We utilize the Moisture Continuum to guide us:
- Dry Wounds: Require moisture donation (e.g., hydrogels).
- Highly Exudative Wounds: Require moisture absorption (e.g., calcium alginates, foams, or super-absorbents) to prevent periwound maceration, which can further damage the edge and stall migration.
5. Advanced Therapies and Biophysical Agents
If the cause is corrected (Statement 9A) but the wound remains stalled at the 4-week mark, we must escalate to active modalities:
- Negative-Pressure Wound Therapy (NPWT): Removes exudate and applies mechanical stress to promote granulation.
- Electrical Stimulation (ES): Delivers low-voltage current to stimulate DNA synthesis and fibroblast migration.
- Ultrasound (Low-frequency): Uses mechanical vibration for cellular-level debridement and healing stimulation.
- Hyperbaric Oxygen Therapy (HBOT): Increases oxygen diffusion in plasma to reverse localized hypoxia.
- Cellular and/or Tissue-Based Products: Includes protease-modulating dressings that rebalance the hostile molecular environment.
6. Conclusion: The 4-Week Rule
In clinical practice, the signal is clear: if a healable wound has not achieved a 20% to 40% surface area reduction by week 4, it is unlikely to heal by week 12 without a change in strategy. A stalled edge is not a reason to wait; it is a mandate to re-verify the diagnosis, confirm the cause is corrected, and escalate to edge-focused therapies that address biofilm and cellular senescence.
7. Clinical Pearls for the Specialist
Practice Pearls
- Audible Handheld Doppler (AHHD): This is a rapid, bedside test for vascular assessment. It is highly specific (97-98%) for excluding peripheral vascular disease, though its sensitivity (30-37%) is low for diagnosing it. It is superior to ABPI in patients with calcified vessels.
- Healability: A wound is only “healable” if the cause is corrected and blood supply is adequate (AHHD triphasic/biphasic signals or ABPI >0.6).
- The Sibbald Cube: Always evaluate both the superficial and deep compartments. Remember that high proteases can stall a wound even in the absence of overt infection.
- Nutritional Screen: Use the two-question Canadian Nutritional Screening Tool (weight loss and decreased eating) to trigger an immediate dietitian referral.
- Dressing Logic: Use “release” antimicrobials (Silver/Iodine) when you need to treat the wound surface, and “non-release” (PHMB gauze) when the goal is to prevent contamination within the dressing.